Cargando…
Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti‐CD19 CAR‐T therapy: a case report
Progressive multifocal leukoencephalopathy (PML) is an opportunistic brain infection with few treatment options and poor survival when reversal of the underlying immune dysfunction is not achievable. JC polyomavirus reactivation resulting in PML can rarely complicate chimeric antigen receptor T‐cell...
Autores principales: | Mackenzie, Strachan, Shafat, Manar, Roddy, Harriet, Hyare, Harpreet, Neill, Lorna, Marzolini, Maria A. V., Gilhooley, Michael, Marafioti, Teresa, Kara, Eleanna, Sanchez, Emilie, Rees, Jeremy, Lynch, David S., Thomson, Kirsty, Ardeshna, Kirit M., Laurence, Arian, Peggs, Karl S., O'Reilly, Maeve, Roddie, Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281485/ https://www.ncbi.nlm.nih.gov/pubmed/35845220 http://dx.doi.org/10.1002/jha2.274 |
Ejemplares similares
-
Lymphocyte morphology in a patient receiving CD19 chimeric antigen receptor T‐cell therapy for mantle cell lymphoma
por: Marzolini, Maria A. V., et al.
Publicado: (2021) -
Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
por: Küpper, Clemens, et al.
Publicado: (2019) -
Single-Dose Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
por: Beudel, Martijn, et al.
Publicado: (2021) -
Sequential interleukin 2 and pembrolizumab use in progressive multifocal leukoencephalopathy
por: Mahler, Christoph, et al.
Publicado: (2020) -
PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy
por: Möhn, Nora, et al.
Publicado: (2021)